Skip to main content

Pfizer Wins in $2.15 Billion Patent Infringement Case

Pfizer settled a nearly 10-year battle Wednesday, announcing a $2.15 billion settlement from Teva Pharmaceuticals Industries and and Sun Pharmaceutical Industries for patent infringement on its drug Protonix.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.